Skip to main content
Top
Published in: Journal of Bioethical Inquiry 4/2017

01-12-2017 | Symposium: Ethics and Epistemology of Big Data

Ethics and Epistemology in Big Data Research

Authors: Wendy Lipworth, Paul H. Mason, Ian Kerridge, John P. A. Ioannidis

Published in: Journal of Bioethical Inquiry | Issue 4/2017

Login to get access

Abstract

Biomedical innovation and translation are increasingly emphasizing research using “big data.” The hope is that big data methods will both speed up research and make its results more applicable to “real-world” patients and health services. While big data research has been embraced by scientists, politicians, industry, and the public, numerous ethical, organizational, and technical/methodological concerns have also been raised. With respect to technical and methodological concerns, there is a view that these will be resolved through sophisticated information technologies, predictive algorithms, and data analysis techniques. While such advances will likely go some way towards resolving technical and methodological issues, we believe that the epistemological issues raised by big data research have important ethical implications and raise questions about the very possibility of big data research achieving its goals.
Literature
go back to reference Aboab, J., L.A. Celi, P. Charlton, et al. 2016. A “datathon” model to support cross-disciplinary collaboration. Science Translational Medicine 8(333): 333ps8. Aboab, J., L.A. Celi, P. Charlton, et al. 2016. A “datathon” model to support cross-disciplinary collaboration. Science Translational Medicine 8(333): 333ps8.
go back to reference Alyass, A., M. Turcotte, and D. Meyre. 2015. From big data analysis to personalized medicine for all: Challenges and opportunities. BMC Medical Genomics 8(1): 33.CrossRefPubMedPubMedCentral Alyass, A., M. Turcotte, and D. Meyre. 2015. From big data analysis to personalized medicine for all: Challenges and opportunities. BMC Medical Genomics 8(1): 33.CrossRefPubMedPubMedCentral
go back to reference Angus, D.C. 2015. Fusing randomized trials with big data: The key to self-learning health care systems? JAMA 314(8): 767–768.CrossRefPubMed Angus, D.C. 2015. Fusing randomized trials with big data: The key to self-learning health care systems? JAMA 314(8): 767–768.CrossRefPubMed
go back to reference Bate, A., J. Juniper, A.M. Lawton, and R.M. Thwaites. 2016. Designing and incorporating a real world data approach to international drug development and use: What the UK offers. Drug Discovery Today 21(3): 400–405.CrossRefPubMed Bate, A., J. Juniper, A.M. Lawton, and R.M. Thwaites. 2016. Designing and incorporating a real world data approach to international drug development and use: What the UK offers. Drug Discovery Today 21(3): 400–405.CrossRefPubMed
go back to reference Bohensky, M.A., D. Jolley, V. Sundararajan, et al. 2010. Data linkage: A powerful research tool with potential problems. BMC Health Services Research 10(1): 346.CrossRefPubMedPubMedCentral Bohensky, M.A., D. Jolley, V. Sundararajan, et al. 2010. Data linkage: A powerful research tool with potential problems. BMC Health Services Research 10(1): 346.CrossRefPubMedPubMedCentral
go back to reference Booth, P. 2015. Access to anonymised patient data: Corners cannot be cut if patient confidence is to be maintained. BMJ 351: h5817.CrossRefPubMed Booth, P. 2015. Access to anonymised patient data: Corners cannot be cut if patient confidence is to be maintained. BMJ 351: h5817.CrossRefPubMed
go back to reference Bourne, P.E., J.R. Lorsch, and E.D. Green. 2015. Perspective: Sustaining the big-data ecosystem. Nature 527(7576): S16–S17.CrossRefPubMed Bourne, P.E., J.R. Lorsch, and E.D. Green. 2015. Perspective: Sustaining the big-data ecosystem. Nature 527(7576): S16–S17.CrossRefPubMed
go back to reference Boyd, D., and K. Crawford. 2012. Critical questions for big data: Provocations for a cultural, technological, and scholarly phenomenon. Information, Communication & Society 15(5): 662–679.CrossRef Boyd, D., and K. Crawford. 2012. Critical questions for big data: Provocations for a cultural, technological, and scholarly phenomenon. Information, Communication & Society 15(5): 662–679.CrossRef
go back to reference Broder, A., L. Adamic, M. Franklin, M.d. Rijke, E. Xing, and K. Yu. 2015. Big data: New paradigm or sound and fury, signifying nothing? In Proceedings of the eighth ACM international conference on web search and data mining, 5–6. Broder, A., L. Adamic, M. Franklin, M.d. Rijke, E. Xing, and K. Yu. 2015. Big data: New paradigm or sound and fury, signifying nothing? In Proceedings of the eighth ACM international conference on web search and data mining, 5–6.
go back to reference Burgio, M.R., J.P. Ioannidis, B.M. Kaminski, et al. 2013. Collaborative cancer epidemiology in the 21st century: The model of cancer consortia. Cancer Epidemiology Biomarkers & Prevention: cebp-0591. Burgio, M.R., J.P. Ioannidis, B.M. Kaminski, et al. 2013. Collaborative cancer epidemiology in the 21st century: The model of cancer consortia. Cancer Epidemiology Biomarkers & Prevention: cebp-0591.
go back to reference Busch, L. 2014. Big data, big questions| A dozen ways to get lost in translation: Inherent challenges in large scale data sets. International Journal of Communication 8: 818. Busch, L. 2014. Big data, big questions| A dozen ways to get lost in translation: Inherent challenges in large scale data sets. International Journal of Communication 8: 818.
go back to reference Callebaut, W. 2012. Scientific perspectivism: A philosopher of science’s response to the challenge of big data biology. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 43(1): 69–80.CrossRef Callebaut, W. 2012. Scientific perspectivism: A philosopher of science’s response to the challenge of big data biology. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 43(1): 69–80.CrossRef
go back to reference Carter, P., G.T. Laurie, and M. Dixon-Woods. 2015. The social licence for research: Why care.data ran into trouble. Journal of Medical Ethics. epub ahead of print, January 23. doi:10.1136/medethics-2014-102374. Carter, P., G.T. Laurie, and M. Dixon-Woods. 2015. The social licence for research: Why care.data ran into trouble. Journal of Medical Ethics. epub ahead of print, January 23. doi:10.​1136/​medethics-2014-102374.
go back to reference Caulfield, T. 2004. Biotechnology and the popular press: Hype and the selling of science. Trends in Biotechnology 22(7): 337–339.CrossRefPubMed Caulfield, T. 2004. Biotechnology and the popular press: Hype and the selling of science. Trends in Biotechnology 22(7): 337–339.CrossRefPubMed
go back to reference Chawla, N.V., and D.A. Davis. 2013. Bringing big data to personalized healthcare: A patient-centered framework. Journal of General Internal Medicine 28(3): 660–665.CrossRefPubMedCentral Chawla, N.V., and D.A. Davis. 2013. Bringing big data to personalized healthcare: A patient-centered framework. Journal of General Internal Medicine 28(3): 660–665.CrossRefPubMedCentral
go back to reference Chen, B., and A.J. Butte. 2016. Leveraging big data to transform target selection and drug discovery. Clinical Pharmacology & Therapeutics 99(3): 285–297.CrossRef Chen, B., and A.J. Butte. 2016. Leveraging big data to transform target selection and drug discovery. Clinical Pharmacology & Therapeutics 99(3): 285–297.CrossRef
go back to reference Chow-White, P.A., M. MacAulay, A. Charters, and P. Chow. 2015. From the bench to the bedside in the big data age: Ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics and Information Technology 17(3): 189–200.CrossRef Chow-White, P.A., M. MacAulay, A. Charters, and P. Chow. 2015. From the bench to the bedside in the big data age: Ethics and practices of consent and privacy for clinical genomics and personalized medicine. Ethics and Information Technology 17(3): 189–200.CrossRef
go back to reference Christen, M., N. Biller-Andorno, B. Bringedal, K. Grimes, J. Savulescu, and H. Walter. 2016. Ethical challenges of simulation-driven big neuroscience. AJOB Neuroscience 7(1): 5–17.CrossRef Christen, M., N. Biller-Andorno, B. Bringedal, K. Grimes, J. Savulescu, and H. Walter. 2016. Ethical challenges of simulation-driven big neuroscience. AJOB Neuroscience 7(1): 5–17.CrossRef
go back to reference Crawford, K., M.L. Gray, and K. Miltner. 2014. Big data| Critiquing big data: Politics, ethics, epistemology| Special section introduction. International Journal of Communication 8: 810. Crawford, K., M.L. Gray, and K. Miltner. 2014. Big data| Critiquing big data: Politics, ethics, epistemology| Special section introduction. International Journal of Communication 8: 810.
go back to reference Crump, C., K. Sundquist, and M.A. Winkleby. 2015. Transnational research partnerships: Leveraging big data to enhance US health. Journal of Epidemiology and Community Health. ePub ahead of print: March 12. doi:10.1136/jech-2015-205451. Crump, C., K. Sundquist, and M.A. Winkleby. 2015. Transnational research partnerships: Leveraging big data to enhance US health. Journal of Epidemiology and Community Health. ePub ahead of print: March 12. doi:10.​1136/​jech-2015-205451.
go back to reference Dereli, T., Y. Coşkun, E. Kolker, Ö. Güner, M. Ağırbaşlı, and V. Özdemir. 2014. Big data and ethics review for health systems research in LMICs: Understanding risk, uncertainty and ignorance—and catching the black swans? The American Journal of Bioethics 14(2): 48–50.CrossRefPubMed Dereli, T., Y. Coşkun, E. Kolker, Ö. Güner, M. Ağırbaşlı, and V. Özdemir. 2014. Big data and ethics review for health systems research in LMICs: Understanding risk, uncertainty and ignorance—and catching the black swans? The American Journal of Bioethics 14(2): 48–50.CrossRefPubMed
go back to reference Dickson, D.J., and J.D. Pfeifer. 2016. Real-world data in the molecular era: Finding the reality in the real world. Clinical Pharmacology & Therapeutics 99(2): 186–197.CrossRef Dickson, D.J., and J.D. Pfeifer. 2016. Real-world data in the molecular era: Finding the reality in the real world. Clinical Pharmacology & Therapeutics 99(2): 186–197.CrossRef
go back to reference Dove, E.S., and V. Özdemir. 2015. What role for law, human rights, and bioethics in an age of big data, consortia science, and consortia ethics? The importance of trustworthiness. Laws 4(3): 515–540.CrossRefPubMedPubMedCentral Dove, E.S., and V. Özdemir. 2015. What role for law, human rights, and bioethics in an age of big data, consortia science, and consortia ethics? The importance of trustworthiness. Laws 4(3): 515–540.CrossRefPubMedPubMedCentral
go back to reference Dove, E.S., B.M. Knoppers, and H.Z. Ma’n. 2013. An ethics safe harbor for international genomics research? Genome Medicine 5(11): 1.CrossRef Dove, E.S., B.M. Knoppers, and H.Z. Ma’n. 2013. An ethics safe harbor for international genomics research? Genome Medicine 5(11): 1.CrossRef
go back to reference Dzau, V.J., and G.S. Ginsburg. 2016. Realizing the full potential of precision medicine in health and health care. JAMA 316(16): 1659–1660.CrossRefPubMed Dzau, V.J., and G.S. Ginsburg. 2016. Realizing the full potential of precision medicine in health and health care. JAMA 316(16): 1659–1660.CrossRefPubMed
go back to reference Erdmann, J. 2013. As personal genomes join big data will privacy and access shrink? Chemistry & Biology 20(1): 1–2.CrossRef Erdmann, J. 2013. As personal genomes join big data will privacy and access shrink? Chemistry & Biology 20(1): 1–2.CrossRef
go back to reference Fiedler, K. 2011. Voodoo correlations are everywhere—Not only in neuroscience. Perspectives on Psychological Science 6(2): 163–171.CrossRefPubMed Fiedler, K. 2011. Voodoo correlations are everywhere—Not only in neuroscience. Perspectives on Psychological Science 6(2): 163–171.CrossRefPubMed
go back to reference Fischer, T., K. Brothers, P. Erdmann, and M. Langanke. 2016. Clinical decision-making and secondary findings in systems medicine. BMC Medical Ethics 17(1): 32.CrossRefPubMedPubMedCentral Fischer, T., K. Brothers, P. Erdmann, and M. Langanke. 2016. Clinical decision-making and secondary findings in systems medicine. BMC Medical Ethics 17(1): 32.CrossRefPubMedPubMedCentral
go back to reference Frizzo-Barker, J., P.A. Chow-White, A. Charters, and D. Ha. 2016. Genomic big data and privacy: Challenges and opportunities for precision medicine. Computer Supported Cooperative Work (CSCW) 25(2–3): 115–136.CrossRef Frizzo-Barker, J., P.A. Chow-White, A. Charters, and D. Ha. 2016. Genomic big data and privacy: Challenges and opportunities for precision medicine. Computer Supported Cooperative Work (CSCW) 25(2–3): 115–136.CrossRef
go back to reference Gal, T.S., T.C. Tucker, A. Gangopadhyay, and Z. Chen. 2014. A data recipient centered de-identification method to retain statistical attributes. Journal of Biomedical Informatics 50: 32–45.CrossRefPubMed Gal, T.S., T.C. Tucker, A. Gangopadhyay, and Z. Chen. 2014. A data recipient centered de-identification method to retain statistical attributes. Journal of Biomedical Informatics 50: 32–45.CrossRefPubMed
go back to reference Gilbert, R., H. Goldstein, and H. Hemingway. 2015. The market in healthcare data. BMJ 4(351): h5897.CrossRef Gilbert, R., H. Goldstein, and H. Hemingway. 2015. The market in healthcare data. BMJ 4(351): h5897.CrossRef
go back to reference Goldstein, B.A., A.M. Navar, M.J. Pencina, and J.P. Ioannidis. 2016. Opportunities and challenges in developing risk prediction models with electronic health records data: A systematic review. Journal of the American Medical Informatics Association 24(1): 198–208.CrossRefPubMed Goldstein, B.A., A.M. Navar, M.J. Pencina, and J.P. Ioannidis. 2016. Opportunities and challenges in developing risk prediction models with electronic health records data: A systematic review. Journal of the American Medical Informatics Association 24(1): 198–208.CrossRefPubMed
go back to reference Goossens, K., K. Van Uytfanghe, P.J. Twomey, and L.M. Thienpont. 2015. Monitoring laboratory data across manufacturers and laboratories—A prerequisite to make “Big Data” work. Clinica Chimica Acta 445: 12–18.CrossRef Goossens, K., K. Van Uytfanghe, P.J. Twomey, and L.M. Thienpont. 2015. Monitoring laboratory data across manufacturers and laboratories—A prerequisite to make “Big Data” work. Clinica Chimica Acta 445: 12–18.CrossRef
go back to reference Hassey, A. 2015. Response of Health and Social Care Information Centre to article on access to anonymised patient data. BMJ 351: h5820.CrossRefPubMed Hassey, A. 2015. Response of Health and Social Care Information Centre to article on access to anonymised patient data. BMJ 351: h5820.CrossRefPubMed
go back to reference Hemkens, L.G., D.G. Contopoulos-Ioannidis, and J.P. Ioannidis. 2016a. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: Meta-epidemiological survey. BMJ 352: i493.CrossRefPubMedPubMedCentral Hemkens, L.G., D.G. Contopoulos-Ioannidis, and J.P. Ioannidis. 2016a. Agreement of treatment effects for mortality from routinely collected data and subsequent randomized trials: Meta-epidemiological survey. BMJ 352: i493.CrossRefPubMedPubMedCentral
go back to reference ———. 2016b. Current use of routinely collected health data to complement randomized controlled trials: A meta-epidemiological survey. CMAJ Open 4(2): E132–E140. ———. 2016b. Current use of routinely collected health data to complement randomized controlled trials: A meta-epidemiological survey. CMAJ Open 4(2): E132–E140.
go back to reference ———. 2016c. Routinely collected data and comparative effectiveness evidence: Promises and limitations. Canadian Medical Association Journal 188(8): E158. ———. 2016c. Routinely collected data and comparative effectiveness evidence: Promises and limitations. Canadian Medical Association Journal 188(8): E158.
go back to reference Hoffman, S. 2010. Electronic health records and research: Privacy versus scientific priorities. The American Journal of Bioethics 10(9): 19–20.CrossRefPubMed Hoffman, S. 2010. Electronic health records and research: Privacy versus scientific priorities. The American Journal of Bioethics 10(9): 19–20.CrossRefPubMed
go back to reference ———. 2016. The promise and perils of open medical data. Hastings Center Report 46(1): 6–7. ———. 2016. The promise and perils of open medical data. Hastings Center Report 46(1): 6–7.
go back to reference Hoffman, S., and A. Podgurski. 2013. Big bad data: Law, public health, and biomedical databases. The Journal of Law, Medicine & Ethics 41(s1): 56–60.CrossRef Hoffman, S., and A. Podgurski. 2013. Big bad data: Law, public health, and biomedical databases. The Journal of Law, Medicine & Ethics 41(s1): 56–60.CrossRef
go back to reference Hood, L., and C. Auffray. 2013. Participatory medicine: A driving force for revolutionizing healthcare. Genome Medicine 5(12): 1–4.CrossRef Hood, L., and C. Auffray. 2013. Participatory medicine: A driving force for revolutionizing healthcare. Genome Medicine 5(12): 1–4.CrossRef
go back to reference Howard, R. 2013. Big data hype cut down to size. Government News 33(5): 26. Howard, R. 2013. Big data hype cut down to size. Government News 33(5): 26.
go back to reference Ioannidis, J.P. 2005a. Microarrays and molecular research: Noise discovery? The Lancet 365(9458): 454–455.CrossRef Ioannidis, J.P. 2005a. Microarrays and molecular research: Noise discovery? The Lancet 365(9458): 454–455.CrossRef
go back to reference ———. 2005b. Why most published research findings are false. PLoS Medicine 2(8): e124. ———. 2005b. Why most published research findings are false. PLoS Medicine 2(8): e124.
go back to reference ———. 2013. Informed consent, big data, and the oxymoron of research that is not research. The American Journal of Bioethics 13(4): 40–42. ———. 2013. Informed consent, big data, and the oxymoron of research that is not research. The American Journal of Bioethics 13(4): 40–42.
go back to reference Janssen, M., E. Estevez, and T. Janowski. 2014. Interoperability in big, open, and linked data—Organizational maturity, capabilities, and data portfolios. Computer 47(10): 44–49.CrossRef Janssen, M., E. Estevez, and T. Janowski. 2014. Interoperability in big, open, and linked data—Organizational maturity, capabilities, and data portfolios. Computer 47(10): 44–49.CrossRef
go back to reference Jee, K., and G.-H. Kim. 2013. Potentiality of big data in the medical sector: Focus on how to reshape the healthcare system. Healthcare Informatics Research 19(2): 79–85.CrossRefPubMedPubMedCentral Jee, K., and G.-H. Kim. 2013. Potentiality of big data in the medical sector: Focus on how to reshape the healthcare system. Healthcare Informatics Research 19(2): 79–85.CrossRefPubMedPubMedCentral
go back to reference Joyner, M.J., N. Paneth, and J.P. Ioannidis. 2016. What happens when underperforming big ideas in research become entrenched? JAMA 316(13): 1355–1356.CrossRefPubMed Joyner, M.J., N. Paneth, and J.P. Ioannidis. 2016. What happens when underperforming big ideas in research become entrenched? JAMA 316(13): 1355–1356.CrossRefPubMed
go back to reference Kaplan, B. 2016. How should health data be used? Privacy, secondary use, and big data sales. Cambridge Quarterly of Healthcare Ethics 25: 312–329.CrossRefPubMed Kaplan, B. 2016. How should health data be used? Privacy, secondary use, and big data sales. Cambridge Quarterly of Healthcare Ethics 25: 312–329.CrossRefPubMed
go back to reference Larson, E.B. 2013. Building trust in the power of “big data” research to serve the public good. JAMA 309(23): 2443–2444.CrossRefPubMed Larson, E.B. 2013. Building trust in the power of “big data” research to serve the public good. JAMA 309(23): 2443–2444.CrossRefPubMed
go back to reference Lazer, D., R. Kennedy, G. King, and A. Vespignani. 2014. The parable of Google flu: Traps in big data analysis. Science 343(6176): 1203–1205.CrossRefPubMed Lazer, D., R. Kennedy, G. King, and A. Vespignani. 2014. The parable of Google flu: Traps in big data analysis. Science 343(6176): 1203–1205.CrossRefPubMed
go back to reference Madigan, D., P.B. Ryan, M. Schuemie, et al. 2013. Evaluating the impact of database heterogeneity on observational study results. American Journal of Epidemiology 178(4): 645–651.CrossRefPubMedPubMedCentral Madigan, D., P.B. Ryan, M. Schuemie, et al. 2013. Evaluating the impact of database heterogeneity on observational study results. American Journal of Epidemiology 178(4): 645–651.CrossRefPubMedPubMedCentral
go back to reference Manrai, A.K., J.P. Ioannidis, and I.S. Kohane. 2016. Clinical genomics: From pathogenicity claims to quantitative risk estimates. JAMA 315(12): 1233–1234.CrossRefPubMed Manrai, A.K., J.P. Ioannidis, and I.S. Kohane. 2016. Clinical genomics: From pathogenicity claims to quantitative risk estimates. JAMA 315(12): 1233–1234.CrossRefPubMed
go back to reference Mason, P., W. Lipworth, and I. Kerridge. 2016. More than one way to be global: Globalisation of research and the contest of ideas. American Journal of Bioethics (Open peer commentary) 16(10): 48–49.CrossRef Mason, P., W. Lipworth, and I. Kerridge. 2016. More than one way to be global: Globalisation of research and the contest of ideas. American Journal of Bioethics (Open peer commentary) 16(10): 48–49.CrossRef
go back to reference Mischak, H., E. Critselis, S. Hanash, W.M. Gallagher, A. Vlahou, and J.P. Ioannidis. 2015. Epidemiologic design and analysis for proteomic studies: A primer on-omic technologies. American Journal of Epidemiology 181(9): 635–647.CrossRefPubMed Mischak, H., E. Critselis, S. Hanash, W.M. Gallagher, A. Vlahou, and J.P. Ioannidis. 2015. Epidemiologic design and analysis for proteomic studies: A primer on-omic technologies. American Journal of Epidemiology 181(9): 635–647.CrossRefPubMed
go back to reference Mittelstadt, B.D., and L. Floridi. 2016. The ethics of big data: Current and foreseeable issues in biomedical contexts. Science and Engineering Ethics 22(2): 303–341.CrossRefPubMed Mittelstadt, B.D., and L. Floridi. 2016. The ethics of big data: Current and foreseeable issues in biomedical contexts. Science and Engineering Ethics 22(2): 303–341.CrossRefPubMed
go back to reference Moore, S.M., D.R. Maffitt, K.E. Smith, et al. 2015. De-identification of medical images with retention of scientific research value. RadioGraphics 35(3): 727–735.CrossRefPubMedPubMedCentral Moore, S.M., D.R. Maffitt, K.E. Smith, et al. 2015. De-identification of medical images with retention of scientific research value. RadioGraphics 35(3): 727–735.CrossRefPubMedPubMedCentral
go back to reference Mostert, M., A.L. Bredenoord, M.C. Biesaart, and J.J. van Delden. 2015. Big Data in medical research and EU data protection law: Challenges to the consent or anonymise approach. European Journal of Human Genetics 24: 956–960.CrossRefPubMedPubMedCentral Mostert, M., A.L. Bredenoord, M.C. Biesaart, and J.J. van Delden. 2015. Big Data in medical research and EU data protection law: Challenges to the consent or anonymise approach. European Journal of Human Genetics 24: 956–960.CrossRefPubMedPubMedCentral
go back to reference Murdoch, T.B., and A.S. Detsky. 2013. The inevitable application of big data to health care. JAMA 309(13): 1351–1352.CrossRefPubMed Murdoch, T.B., and A.S. Detsky. 2013. The inevitable application of big data to health care. JAMA 309(13): 1351–1352.CrossRefPubMed
go back to reference Nair, V., C. Pritchard, M. Tewari, and J. Ioannidis. 2014. Design and analysis for studying microRNAs in human disease: A primer on -omic Technologies. American Journal of Epidemiology 180(2): 140–152.CrossRefPubMedPubMedCentral Nair, V., C. Pritchard, M. Tewari, and J. Ioannidis. 2014. Design and analysis for studying microRNAs in human disease: A primer on -omic Technologies. American Journal of Epidemiology 180(2): 140–152.CrossRefPubMedPubMedCentral
go back to reference Newman, A.L. 2015. What the “right to be forgotten” means for privacy in a digital age. Science 347(6221): 507–508.CrossRefPubMed Newman, A.L. 2015. What the “right to be forgotten” means for privacy in a digital age. Science 347(6221): 507–508.CrossRefPubMed
go back to reference Oye, K.A., G. Jain, M. Amador, et al. 2015. The next frontier: Fostering innovation by improving health data access and utilization. Clinical Pharmacology & Therapeutics 98(5): 514–521.CrossRef Oye, K.A., G. Jain, M. Amador, et al. 2015. The next frontier: Fostering innovation by improving health data access and utilization. Clinical Pharmacology & Therapeutics 98(5): 514–521.CrossRef
go back to reference Parikh, R.B., M. Kakad, and D.W. Bates. 2016. Integrating predictive analytics into high-value care: The dawn of precision delivery. JAMA 315(7): 651–652.CrossRefPubMed Parikh, R.B., M. Kakad, and D.W. Bates. 2016. Integrating predictive analytics into high-value care: The dawn of precision delivery. JAMA 315(7): 651–652.CrossRefPubMed
go back to reference Patel, C.J., B. Burford, and J.P. Ioannidis. 2015. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. Journal of Clinical Epidemiology 68(9): 1046–1058.CrossRefPubMedPubMedCentral Patel, C.J., B. Burford, and J.P. Ioannidis. 2015. Assessment of vibration of effects due to model specification can demonstrate the instability of observational associations. Journal of Clinical Epidemiology 68(9): 1046–1058.CrossRefPubMedPubMedCentral
go back to reference Patel, C.J., J. Ji, J. Sundquist, J.P. Ioannidis, and K. Sundquist. 2016. Systematic assessment of pharmaceutical prescriptions in association with cancer risk: A method to conduct a population-wide medication-wide longitudinal study. Scientific Reports 6(Aug 10): 31308.CrossRefPubMedPubMedCentral Patel, C.J., J. Ji, J. Sundquist, J.P. Ioannidis, and K. Sundquist. 2016. Systematic assessment of pharmaceutical prescriptions in association with cancer risk: A method to conduct a population-wide medication-wide longitudinal study. Scientific Reports 6(Aug 10): 31308.CrossRefPubMedPubMedCentral
go back to reference Ploug, T., and S. Holm. 2015. Meta consent: A flexible and autonomous way of obtaining informed consent for secondary research. BMJ 350: h2146.CrossRefPubMed Ploug, T., and S. Holm. 2015. Meta consent: A flexible and autonomous way of obtaining informed consent for secondary research. BMJ 350: h2146.CrossRefPubMed
go back to reference Prasser, F., F. Kohlmayer, and K.A. Kuhn. 2016a. Efficient and effective pruning strategies for health data de-identification. BMC Medical Informatics and Decision Making 16(1): 1.CrossRef Prasser, F., F. Kohlmayer, and K.A. Kuhn. 2016a. Efficient and effective pruning strategies for health data de-identification. BMC Medical Informatics and Decision Making 16(1): 1.CrossRef
go back to reference ———. 2016b. The importance of context: Risk-based de-identification of biomedical data. Methods of Information in Medicine 55(4): 347–355. ———. 2016b. The importance of context: Risk-based de-identification of biomedical data. Methods of Information in Medicine 55(4): 347–355.
go back to reference Puschmann, C., and J. Burgess. 2014. Big data, big questions| Metaphors of big data. International Journal of Communication 8: 820. Puschmann, C., and J. Burgess. 2014. Big data, big questions| Metaphors of big data. International Journal of Communication 8: 820.
go back to reference Raghupathi, W., and V. Raghupathi. 2014. Big data analytics in healthcare: Promise and potential. Health Information Science and Systems 2(1): 1–10.CrossRef Raghupathi, W., and V. Raghupathi. 2014. Big data analytics in healthcare: Promise and potential. Health Information Science and Systems 2(1): 1–10.CrossRef
go back to reference Roden, D.M., and J.C. Denny. 2016. Integrating electronic health record genotype and phenotype datasets to transform patient care. Clinical Pharmacology & Therapeutics 99(3): 298–305.CrossRef Roden, D.M., and J.C. Denny. 2016. Integrating electronic health record genotype and phenotype datasets to transform patient care. Clinical Pharmacology & Therapeutics 99(3): 298–305.CrossRef
go back to reference Roski, J., G.W. Bo-Linn, and T.A. Andrews. 2014. Creating value in health care through big data: Opportunities and policy implications. Health Affairs 33(7): 1115–1122.CrossRefPubMed Roski, J., G.W. Bo-Linn, and T.A. Andrews. 2014. Creating value in health care through big data: Opportunities and policy implications. Health Affairs 33(7): 1115–1122.CrossRefPubMed
go back to reference Rothstein, M.A. 2015. Ethical issues in big data health research: Currents in contemporary bioethics. The Journal of Law, Medicine & Ethics 43(2): 425–429.CrossRef Rothstein, M.A. 2015. Ethical issues in big data health research: Currents in contemporary bioethics. The Journal of Law, Medicine & Ethics 43(2): 425–429.CrossRef
go back to reference Rothwell, P.M. 2005. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation. The Lancet 365(9454): 176–186.CrossRef Rothwell, P.M. 2005. Subgroup analysis in randomised controlled trials: Importance, indications, and interpretation. The Lancet 365(9454): 176–186.CrossRef
go back to reference Ryan, P.B., D. Madigan, P.E. Stang, J. Marc Overhage, J.A. Racoosin, and A.G. Hartzema. 2012. Empirical assessment of methods for risk identification in healthcare data: Results from the experiments of the Observational Medical Outcomes Partnership. Statistics in Medicine 31(30): 4401–4415.CrossRefPubMed Ryan, P.B., D. Madigan, P.E. Stang, J. Marc Overhage, J.A. Racoosin, and A.G. Hartzema. 2012. Empirical assessment of methods for risk identification in healthcare data: Results from the experiments of the Observational Medical Outcomes Partnership. Statistics in Medicine 31(30): 4401–4415.CrossRefPubMed
go back to reference Sacristán, J.A., and T. Dilla. 2015. No big data without small data: Learning health care systems begin and end with the individual patient. Journal of Evaluation in Clinical Practice 21(6): 1014–1017.CrossRefPubMed Sacristán, J.A., and T. Dilla. 2015. No big data without small data: Learning health care systems begin and end with the individual patient. Journal of Evaluation in Clinical Practice 21(6): 1014–1017.CrossRefPubMed
go back to reference Sboner, A., X.J. Mu, D. Greenbaum, R.K. Auerbach, and M.B. Gerstein. 2011. The real cost of sequencing: Higher than you think! Genome Biology 12(8): 1.CrossRef Sboner, A., X.J. Mu, D. Greenbaum, R.K. Auerbach, and M.B. Gerstein. 2011. The real cost of sequencing: Higher than you think! Genome Biology 12(8): 1.CrossRef
go back to reference Scaiano, M., G. Middleton, L. Arbuckle, et al. 2016. A unified framework for evaluating the risk of re-identification of text de-identification tools. Journal of Biomedical Informatics 63: 174–183.CrossRefPubMed Scaiano, M., G. Middleton, L. Arbuckle, et al. 2016. A unified framework for evaluating the risk of re-identification of text de-identification tools. Journal of Biomedical Informatics 63: 174–183.CrossRefPubMed
go back to reference Schneeweiss, S., and J. Avorn. 2005. A review of uses of health care utilization databases for epidemiologic research on therapeutics. Journal of Clinical Epidemiology 58(4): 323–337.CrossRefPubMed Schneeweiss, S., and J. Avorn. 2005. A review of uses of health care utilization databases for epidemiologic research on therapeutics. Journal of Clinical Epidemiology 58(4): 323–337.CrossRefPubMed
go back to reference Shah, N.H., and J.D. Tenenbaum. 2012. The coming age of data-driven medicine: Translational bioinformatics’ next frontier. Journal of the American Medical Informatics Association 19(e1): e2–e4.CrossRefPubMedPubMedCentral Shah, N.H., and J.D. Tenenbaum. 2012. The coming age of data-driven medicine: Translational bioinformatics’ next frontier. Journal of the American Medical Informatics Association 19(e1): e2–e4.CrossRefPubMedPubMedCentral
go back to reference Shoenbill, K., N. Fost, U. Tachinardi, and E.A. Mendonca. 2014. Genetic data and electronic health records: A discussion of ethical, logistical and technological considerations. Journal of the American Medical Informatics Association 21(1): 171–180.CrossRefPubMed Shoenbill, K., N. Fost, U. Tachinardi, and E.A. Mendonca. 2014. Genetic data and electronic health records: A discussion of ethical, logistical and technological considerations. Journal of the American Medical Informatics Association 21(1): 171–180.CrossRefPubMed
go back to reference Stoeklé, H.-C., M.-F. Mamzer-Bruneel, G. Vogt, and C. Hervé. 2016. 23andMe: A new two-sided data-banking market model. BMC Medical Ethics 17(1): 1.CrossRef Stoeklé, H.-C., M.-F. Mamzer-Bruneel, G. Vogt, and C. Hervé. 2016. 23andMe: A new two-sided data-banking market model. BMC Medical Ethics 17(1): 1.CrossRef
go back to reference Swan, M. 2013. The quantified self: Fundamental disruption in big data science and biological discovery. Big Data 1(2): 85–99.CrossRefPubMed Swan, M. 2013. The quantified self: Fundamental disruption in big data science and biological discovery. Big Data 1(2): 85–99.CrossRefPubMed
go back to reference ———. 2012. Protecting patient privacy in the age of big data. UMKC Law Review 81: 385. ———. 2012. Protecting patient privacy in the age of big data. UMKC Law Review 81: 385.
go back to reference Terry, N. 2013. Big data proxies and health privacy exceptionalism. Health Matrix 2465-108. Terry, N. 2013. Big data proxies and health privacy exceptionalism. Health Matrix 2465-108.
go back to reference Tzoulaki, I., T.M. Ebbels, A. Valdes, P. Elliott, and J.P. Ioannidis. 2014. Design and analysis of metabolomics studies in epidemiological research: A primer on-omic technologies. American Journal of Epidemiology 180(2): 129–139.CrossRefPubMed Tzoulaki, I., T.M. Ebbels, A. Valdes, P. Elliott, and J.P. Ioannidis. 2014. Design and analysis of metabolomics studies in epidemiological research: A primer on-omic technologies. American Journal of Epidemiology 180(2): 129–139.CrossRefPubMed
go back to reference Vayena, E., M. Salathé, L.C. Madoff, and J.S. Brownstein. 2015. Ethical challenges of big data in public health. PLoS Computational Biology 11(2): e1003904.CrossRefPubMedPubMedCentral Vayena, E., M. Salathé, L.C. Madoff, and J.S. Brownstein. 2015. Ethical challenges of big data in public health. PLoS Computational Biology 11(2): e1003904.CrossRefPubMedPubMedCentral
go back to reference Vicini, P., O. Fields, E. Lai, et al. 2016. Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development. Clinical Pharmacology & Therapeutics 99(2): 198–207.CrossRef Vicini, P., O. Fields, E. Lai, et al. 2016. Precision medicine in the age of big data: The present and future role of large-scale unbiased sequencing in drug discovery and development. Clinical Pharmacology & Therapeutics 99(2): 198–207.CrossRef
go back to reference Waldman, S., and A. Terzic. 2016. Big data transforms discovery–utilization therapeutics continuum. Clinical Pharmacology & Therapeutics 99(3): 250–254.CrossRef Waldman, S., and A. Terzic. 2016. Big data transforms discovery–utilization therapeutics continuum. Clinical Pharmacology & Therapeutics 99(3): 250–254.CrossRef
go back to reference Weber, G.M., K.D. Mandl, and I.S. Kohane. 2014. Finding the missing link for big biomedical data. JAMA 311(24): 2479–2480.PubMed Weber, G.M., K.D. Mandl, and I.S. Kohane. 2014. Finding the missing link for big biomedical data. JAMA 311(24): 2479–2480.PubMed
go back to reference Zarate, O.A., J.G. Brody, P. Brown, M.D. Ramirez‐Andreotta, L. Perovich, and J. Matz. 2016. Balancing benefits and risks of immortal data. Hastings Center Report 46(1): 36–45.CrossRefPubMed Zarate, O.A., J.G. Brody, P. Brown, M.D. Ramirez‐Andreotta, L. Perovich, and J. Matz. 2016. Balancing benefits and risks of immortal data. Hastings Center Report 46(1): 36–45.CrossRefPubMed
go back to reference Zuccon, G., D. Kotzur, A. Nguyen, and A. Bergheim. 2014. De-identification of health records using Anonym: Effectiveness and robustness across datasets. Artificial Intelligence in Medicine 61(3): 145–151.CrossRefPubMed Zuccon, G., D. Kotzur, A. Nguyen, and A. Bergheim. 2014. De-identification of health records using Anonym: Effectiveness and robustness across datasets. Artificial Intelligence in Medicine 61(3): 145–151.CrossRefPubMed
go back to reference Zulman, D.M., N.H. Shah, and A. Verghese. 2016. Evolutionary pressures on the electronic health record: Caring for complexity. JAMA 316(9): 923–924.CrossRefPubMed Zulman, D.M., N.H. Shah, and A. Verghese. 2016. Evolutionary pressures on the electronic health record: Caring for complexity. JAMA 316(9): 923–924.CrossRefPubMed
Metadata
Title
Ethics and Epistemology in Big Data Research
Authors
Wendy Lipworth
Paul H. Mason
Ian Kerridge
John P. A. Ioannidis
Publication date
01-12-2017
Publisher
Springer Netherlands
Published in
Journal of Bioethical Inquiry / Issue 4/2017
Print ISSN: 1176-7529
Electronic ISSN: 1872-4353
DOI
https://doi.org/10.1007/s11673-017-9771-3

Other articles of this Issue 4/2017

Journal of Bioethical Inquiry 4/2017 Go to the issue